Genetic testing services provider Prenetics, a spinout of City University of Hong Kong, will hold a reverse merger at a $1.25bn valuation.
Prenetics, a China-based genetic testing services spinout from City University of Hong Kong, is set for a reverse merger with special purpose acquisition company Artisan Acquisition Corp.
Prenetics will be valued at approximately $1.25bn through the deal and will take over Artisan’s listing on the Nasdaq Capital Market, which it received through a $399m initial public offering in May this year.
Artisan was founded by Adrian Cheng, CEO of property conglomerate New World Development, and will provide Prenetics…
